Cargando…
PCMT1 knockdown attenuates malignant properties by globally regulating transcriptome profiles in triple-negative breast cancer cells
BACKGROUND: As the most frequently diagnosed cancer in women, Breast cancer has high mortality and metastasis rate, especially triple-negative breast cancer (TNBC). As an oncogene, protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1) is a prognostic biomarker in breast cancer and is high...
Autores principales: | Saiding, Aili, Maimaitiyiming, Dilinuer, Chen, Minglan, Yan, Futian, Chen, Dong, Hu, Xinyu, Shi, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634331/ https://www.ncbi.nlm.nih.gov/pubmed/37953789 http://dx.doi.org/10.7717/peerj.16006 |
Ejemplares similares
-
LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1
por: Dong, Li-Ming, et al.
Publicado: (2021) -
Wortmannin Reduces Insulin Signaling and Death in Seizure-Prone Pcmt1(−/−) Mice
por: MacKay, Kennen B., et al.
Publicado: (2012) -
LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
por: Aini, Shataer, et al.
Publicado: (2022) -
PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer
por: Guo, Jufang, et al.
Publicado: (2022) -
Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer
por: Shan, Liyun, et al.
Publicado: (2022)